Yonggang Li Selected Research

Neuregulin-1 (Neuregulin 1)

10/2019	Neuroprotection by Exogenous and Endogenous Neuregulin-1 in Mouse Models of Focal Ischemic Stroke.
11/2018	Evaluation of neuregulin-1's neuroprotection against ischemic injury in rats using diffusion tensor imaging.
1/2018	Transcriptomic analysis of neuregulin-1 regulated genes following ischemic stroke by computational identification of promoter binding sites: A role for the ETS-1 transcription factor.
1/2016	Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the NF-kappa B pathway.
10/2015	Spatio-temporal assessment of the neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI.
4/2015	Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury.
12/2007	Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yonggang Li Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 06/2008
7	Ischemic Stroke 03/2024 - 12/2007
6	Infections 01/2024 - 09/2005
6	Osteosarcoma (Osteogenic Sarcoma) 10/2023 - 06/2012
5	Wounds and Injuries (Trauma) 01/2024 - 10/2018
5	Stroke (Strokes) 11/2022 - 10/2015
4	Cognitive Dysfunction 02/2024 - 10/2016
4	Inflammation (Inflammations) 01/2024 - 04/2014
4	Ischemia 01/2018 - 12/2007
3	Pain (Aches) 01/2024 - 12/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2017
3	Pneumonia (Pneumonitis) 01/2023 - 10/2015
3	Infarction (Infarctions) 11/2022 - 12/2007
3	Neoplasm Metastasis (Metastasis) 08/2022 - 04/2009
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2014
3	Congenital Heart Defects (Congenital Heart Defect) 08/2021 - 01/2020
3	Brain Ischemia (Cerebral Ischemia) 10/2019 - 12/2007
3	Hypoxia (Hypoxemia) 08/2018 - 09/2017
3	Hyperthermia 03/2017 - 01/2016
3	Seizures (Absence Seizure) 10/2016 - 06/2011
2	COVID-19 01/2024 - 06/2023
2	Azoospermia 03/2023 - 01/2023
2	Femoral Neck Fractures 10/2022 - 07/2014
2	Glioma (Gliomas) 12/2021 - 05/2016
2	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 05/2021 - 03/2012
2	Lymphatic Metastasis 05/2021 - 11/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
2	Neuroinflammatory Diseases 12/2019 - 10/2016
2	Necrosis 03/2019 - 07/2018
2	Carcinogenesis 01/2019 - 06/2008
2	Hyponatremia 09/2018 - 01/2017
2	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 01/2016
2	Brain Injuries (Brain Injury) 04/2015 - 02/2013
2	Fibrosis (Cirrhosis) 11/2014 - 04/2014
2	Hepatitis B 04/2014 - 01/2012
1	Liver Neoplasms (Liver Cancer) 04/2024
1	Circulating Neoplastic Cells 02/2024

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2007
7	Neuregulin-1 (Neuregulin 1)IBA 10/2019 - 12/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
4	Protons (Proton)IBA 03/2024 - 01/2022
4	gamma-Aminobutyric Acid (GABA)IBA 02/2024 - 01/2022
4	OxidesIBA 01/2023 - 12/2018
4	Neuroprotective AgentsIBA 10/2019 - 04/2015
4	Therapeutic UsesIBA 01/2019 - 07/2014
4	ferric oxide (iron oxide)IBA 01/2018 - 08/2013
3	PolymersIBA 02/2024 - 12/2011
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 07/2007
3	Long Noncoding RNAIBA 10/2023 - 01/2019
3	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023 - 01/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 12/2013
3	FluoridesIBA 10/2021 - 01/2018
3	Oxygen (Dioxygen)IBA 11/2020 - 04/2018
3	Matrix Metalloproteinases (MMPs)IBA 03/2019 - 06/2012
3	InterleukinsIBA 03/2019 - 04/2014
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2013
3	Isoflurophate (DFP)FDA Link 10/2016 - 06/2011
3	LigandsIBA 10/2016 - 04/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2013
2	Cytidine Triphosphate (CTP)IBA 03/2024 - 11/2022
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2023 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 12/2022 - 01/2022
2	AntigensIBA 08/2022 - 10/2015
2	TitaniumIBA 02/2022 - 01/2008
2	CytokinesIBA 01/2022 - 07/2018
2	Coloring Agents (Dyes)IBA 11/2020 - 12/2011
2	SodiumIBA 09/2018 - 01/2017
2	Tolvaptan FDA Link 09/2018 - 01/2017
2	EnzymesIBA 09/2017 - 07/2007
2	Ganciclovir (Cytovene)FDA LinkGeneric 03/2017 - 01/2016
2	Thymidine KinaseIBA 03/2017 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2017 - 01/2016
2	LuciferasesIBA 01/2017 - 01/2016
2	Contrast MediaIBA 12/2015 - 10/2013
2	Plant ExtractsIBA 12/2015 - 11/2014
2	Photosensitizing Agents (Photosensitizers)IBA 05/2015 - 07/2014
2	AlbuminsIBA 05/2015 - 11/2014
2	phytochlorinIBA 05/2015 - 07/2014
2	Small Interfering RNA (siRNA)IBA 08/2014 - 07/2007
2	ZincIBA 12/2013 - 04/2009
2	Drug CarriersIBA 10/2013 - 08/2013
2	Cholinergic Agents (Cholinergics)IBA 07/2012 - 06/2011
2	CurcuminIBA 06/2012 - 06/2008
1	Investigational DrugsIBA 04/2024
1	Antisense OligonucleotidesIBA 04/2024
1	AmidesIBA 03/2024
1	HydrogelsIBA 02/2024

Therapy/Procedure

24	Therapeutics 03/2024 - 12/2011
14	Precision Medicine 08/2018 - 12/2011
9	Photothermal Therapy 03/2024 - 11/2014
7	Drug Therapy (Chemotherapy) 07/2020 - 06/2008
6	Lasers (Laser) 03/2024 - 03/2012
4	Immunotherapy 01/2024 - 01/2021
3	Length of Stay 01/2024 - 12/2015
3	Photochemotherapy (Photodynamic Therapy) 01/2023 - 08/2014
3	Radiotherapy 07/2020 - 04/2018
3	Intravenous Injections 02/2016 - 03/2012
2	Phototherapy (Light Therapy) 03/2024 - 02/2024
2	Blood Transfusion (Blood Transfusions) 10/2022 - 04/2021